Efficacy of Therapeutic Plasma Exchange in Severe Immune Hemolytic Anemia Induced by a Carboplatin Desensitization Procedure
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Journal of investigational allergology & clinical immunology - 31(2021), 2 vom: 20. Apr., Seite 178-179 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vilà-Nadal, G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Allergens |
|---|
| Anmerkungen: |
Date Completed 29.11.2021 Date Revised 29.11.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.18176/jiaci.0634 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313077355 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313077355 | ||
| 003 | DE-627 | ||
| 005 | 20231225145808.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18176/jiaci.0634 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1043.xml |
| 035 | |a (DE-627)NLM313077355 | ||
| 035 | |a (NLM)32732185 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Vilà-Nadal, G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Efficacy of Therapeutic Plasma Exchange in Severe Immune Hemolytic Anemia Induced by a Carboplatin Desensitization Procedure |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.11.2021 | ||
| 500 | |a Date Revised 29.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Carboplatin | |
| 650 | 4 | |a Drug-induced immune hemolytic anemia | |
| 650 | 4 | |a Immunohematology | |
| 650 | 4 | |a Therapeutic apheresis | |
| 650 | 7 | |a Allergens |2 NLM | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Carboplatin |2 NLM | |
| 650 | 7 | |a BG3F62OND5 |2 NLM | |
| 700 | 1 | |a Fiandor Román, A |e verfasserin |4 aut | |
| 700 | 1 | |a Heredia Revuelto, R |e verfasserin |4 aut | |
| 700 | 1 | |a Hernández-Maraver, D |e verfasserin |4 aut | |
| 700 | 1 | |a Kerguelen Fuentes, A E |e verfasserin |4 aut | |
| 700 | 1 | |a Ramírez García, E |e verfasserin |4 aut | |
| 700 | 1 | |a Cabañas Moreno, R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of investigational allergology & clinical immunology |d 1991 |g 31(2021), 2 vom: 20. Apr., Seite 178-179 |w (DE-627)NLM012659215 |x 1018-9068 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2021 |g number:2 |g day:20 |g month:04 |g pages:178-179 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18176/jiaci.0634 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2021 |e 2 |b 20 |c 04 |h 178-179 | ||